Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma
Byun, Joo-Yun, Huang, Kun, Lee, Jong Suk, Huang, Wenjie, Hu, Li, Zheng, Xuyu, Tang, Xin, Li, Fengzeng, Jo, Dong-Gyu, Song, Xinmao, Huang, Chuang
Published in Oncogene (25.02.2022)
Published in Oncogene (25.02.2022)
Get full text
Journal Article
Target modulation and pharmacokinetics/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection
Byun, Joo-Yun, Koh, Yi T., Jang, Sun Young, Witcher, Jennifer W., Chan, Jason R., Pustilnik, Anna, Daniels, Mark J., Kim, Young Hoon, Suh, Kwee Hyun, Linnik, Matthew D., Lee, Young-Mi
Published in Scientific reports (21.09.2021)
Published in Scientific reports (21.09.2021)
Get full text
Journal Article
HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus
Kim, Yu-Yon, Park, Ki Tae, Jang, Sun Young, Lee, Kyu Hang, Byun, Joo-Yun, Suh, Kwee Hyun, Lee, Young-Mi, Kim, Young Hoon, Hwang, Kwang Woo
Published in Arthritis research & therapy (26.09.2017)
Published in Arthritis research & therapy (26.09.2017)
Get full text
Journal Article
The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras
Byun, Joo-Yun, Yoon, Chang-Hwan, An, Sungkwan, Park, In-Chul, Kang, Chang-Mo, Kim, Min-Jung, Lee, Su-Jae
Published in Carcinogenesis (New York) (01.11.2009)
Published in Carcinogenesis (New York) (01.11.2009)
Get full text
Journal Article
Synthesis and Evaluation of a 3,4‐dihydro‐2H‐benzoxazine Derivative as a Potent CDK9 Inhibitor for Anticancer Therapy
Song, Taehun, Lee, Moonsub, Bae, Inhwan, Byun, Joo‐Yun, Ahn, Young Gil, Kim, Young Hoon, Chun, Young‐Jin
Published in Bulletin of the Korean Chemical Society (01.03.2021)
Published in Bulletin of the Korean Chemical Society (01.03.2021)
Get full text
Journal Article
Reactive Oxygen Species-Dependent Activation of Bax and Poly(ADP-ribose) Polymerase-1 Is Required for Mitochondrial Cell Death Induced by Triterpenoid Pristimerin in Human Cervical Cancer Cells
Byun, Joo-Yun, Kim, Min-Jung, Eum, Da-Young, Yoon, Chang-Hwan, Seo, Woo-Duck, Park, Ki Hun, Hyun, Jin-Won, Lee, Yun-Sil, Lee, Jae-Seong, Yoon, Moon-Young, Lee, Su-Jae
Published in Molecular pharmacology (01.10.2009)
Published in Molecular pharmacology (01.10.2009)
Get full text
Journal Article
HM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
Park, Jin Kyun, Byun, Joo-Yun, Park, Ji Ah, Kim, Yu-Yon, Lee, Ye Ji, Oh, Jeong In, Jang, Sun Young, Kim, Young Hoon, Song, Yeong Wook, Son, Jeewoong, Suh, Kwee Hyun, Lee, Young-Mi, Lee, Eun Bong
Published in Arthritis research & therapy (18.04.2016)
Published in Arthritis research & therapy (18.04.2016)
Get full text
Journal Article
Design and synthesis of 4th generation EGFR inhibitors against human triple (Del19/T790M/C797S) mutation
Jeon, Jiyoung, Jang, Sun Young, Kwak, Eun Joo, Lee, Sun Hoe, Byun, Joo-Yun, Kim, Yu-Yon, Ahn, Young Gil, Singh, Pargat, Moon, Kyeongwon, Kim, In Su
Published in European journal of medicinal chemistry (05.12.2023)
Published in European journal of medicinal chemistry (05.12.2023)
Get full text
Journal Article
Activation of p38 Mitogen-Activated Protein Kinase Is Required for Death Receptor–Independent Caspase-8 Activation and Cell Death in Response to Sphingosine
Yoon, Chang-Hwan, Kim, Min-Jung, Park, Moon-Taek, Byun, Joo-Yun, Choi, Young-Hyun, Yoo, Hwan-Soo, Lee, Yong-Moon, Hyun, Jin-Won, Lee, Su-Jae
Published in Molecular cancer research (01.03.2009)
Published in Molecular cancer research (01.03.2009)
Get full text
Journal Article
Triterpenoid pristimerin synergizes with taxol to induce cervical cancer cell death through reactive oxygen species-mediated mitochondrial dysfunction
Eum, Da-Young, Byun, Joo-Yun, Yoon, Chang-Hwan, Seo, Woo-Duck, Park, Ki-Hun, Lee, Jin-Hwan, Chung, Hee Young, An, Sungkwan, Suh, Yongjoon, Kim, Min-Jung, Lee, Su-Jae
Published in Anti-cancer drugs (01.09.2011)
Published in Anti-cancer drugs (01.09.2011)
Get more information
Journal Article
Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell death
Byun, Joo-Yun, Kim, Min-Jung, Yoon, Chang-Hwan, Cha, Hyukjin, Yoon, Gyesoon, Lee, Su-Jae
Published in Molecular cancer research (01.09.2009)
Published in Molecular cancer research (01.09.2009)
Get full text
Journal Article
Activation of Lck is critically required for sphingosine-induced conformational activation of Bak and mitochondrial cell death
Kim, Min-Jung, Park, Moon-Taek, Yoon, Chang-Hwan, Byun, Joo-Yun, Lee, Su-Jae
Published in Biochemical and biophysical research communications (30.05.2008)
Published in Biochemical and biophysical research communications (30.05.2008)
Get full text
Journal Article
Abstract 1257: HM43239, a novel FLT3 inhibitor, has the potential to inhibit mutations resistant to FLT3 inhibitors
Bae, Inhwan, Choi, Jaeyul, Song, Jiyoung, Byun, Joo-Yun, Lee, Eunyoung, Song, Taehun, Kim, Yu-Yon, Bak, Yesol, Kim, Young Hoon, Ahn, Young Gil, Suh, Kwee Hyun
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 1474: Antitumor activity of belvarafenib in melanoma brain metastasis and NRAS mutation melanoma models
Bae, Inhwan, Kim, Yu-Yon, Kim, Jisook, Park, Hyunjin, Song, Taehyun, Byun, Joo-Yun, Lim, Semi, Kim, Young Hoon, Ahn, Young Gil, Suh, Kwee Hyun
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 1704: Discovery and characterization of a novel triple A1/A2a/A2b adenosine receptor antagonist for cancer immunotherapy
Jang, Sunyoung, Jun, Seunah, Lee, Hosun, Lee, Yongtaek, Byun, Joo-Yun, Park, Junghwa, Kim, Yu-Yon, Ahn, Young Gil, Kim, YoungHoon, Suh, Kwee Hyun
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 1135: Antitumor activity of novel reversible LSD1 inhibitors in preclinical models of AML and SCLC
Byun, Joo-Yun, Lee, Won Jong, Kim, Won jung, Kim, Minjeong, Bae, Inhwan, Hong, Seokhyun, Kim, Yu-Yon, Park, Hyunjin, Kim, Eunyoung, Kim, Young Hoon, Ahn, Young Gil, Suh, Kwee Hyun
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 804: Antitumor activity of the potent and novel FLT3 inhibitor HM43239 in acute myeloid leukemia
Lee, Miyoung, Ha, Young Eun, Moon, Mi Jin, Byun, Joo-Yun, Yu, HyunKyung, Kang, SeokJong, Lee, JaeHo, Lee, Kyuhang, Kim, Eunkyung, Kim, Eunyoung, Lee, Ho Jeong, Kim, YoungHoon, Ahn, YoungGil, Suh, KweeHyun, Kim, Sun-Jin
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 4871: Antitumor activity of novel reversible LSD1 inhibitor, HM97211 in preclinical models of SCLC
Bae, InHwan, Kim, JiSook, Park, ChangHee, Kim, Hyeongki, Gwangmog, Namgoong, Byun, Joo-Yun, Hong, Seokhyun, Song, Teahun, Lee, JaeHo, Lee, Kyuhang, Ko, Myoungsil, Kim, Cheolkyung, Lee, YoungMi, Lee, Ho Jeong, Kim, YoungHoon, Ahn, YoungGil, Suh, KweeHyun, Kim, Sun-Jin
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article